Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Biotechnology|February 1, 1993
Whole cell assays in screening for biologically active substancesR P HertzbergCurrent Opinion in Chemical Biology|August 26, 2000
High-throughput screening: new technology for the 21st centuryR P Hertzberg, A J PopeBiochemistry|August 14, 1984
Cleavage of DNA with methidiumpropyl-EDTA-iron(II): reaction conditions and product analysesR P Hertzberg, P B DervanBiochemistry|September 24, 1985
DNA methylation diminishes bleomycin-mediated strand scissionR P Hertzberg, M J Caranfa, S M HechtBiochemistry|May 3, 1988
Degradation of structurally modified DNAs by bleomycin group antibioticsR P Hertzberg, M J Caranfa, S M HechtBiochemistry|May 30, 1989
On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complexR P Hertzberg, M J Caranfa, S M HechtProceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Map of distamycin, netropsin, and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA.Fe(II)M W Van Dyke, R P Hertzberg, P B DervanProceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Cleavage of chromatin with methidiumpropyl-EDTA . iron(II)I L Cartwright, R P Hertzberg, P B Dervan, et al.Biochemistry|March 25, 1986
DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugsR P Hertzberg, S M Hecht, V L Reynolds, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cellsK B Tan, M R Mattern, R A Boyce, et al.Pageof 3